Stay updated with breaking news from Wayne Weisman. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
CoreRx set to acquire Societal CDMO in a $1.10 per share cash deal. Gain insights into this strategic move for drug formulation and manufacturing. Transaction expected to close in Q2 2024.
Societal CDMO to be Acquired by CoreRx, Inc. to Create an Enhanced CDMO with Broad Capabilities Spanning Early-Stage Formulation Development through...
Societal CDMO to be Acquired by CoreRx, Inc. to Create an Enhanced CDMO with Broad Capabilities Spanning Early-Stage Formulation Development through Commercial Manufacturing and Packaging CoreRx to...
Operator: Good day, ladies and gentlemen, and welcome to the Societal CDMO Third Quarter 2023 Financial Results Conference Call. At this time, all participants are in a listen-only mode.
Strategic Realignment Designed to Right Size Organization to Address Macro Pharma Market Financing Challenges and Increase Operational Efficiency in Areas...